RNU6-919P

Across TCGA pan-cancer cohorts, RNU6-919P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-919P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-919P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-919P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

KIRC, LIHC, and KICH are the cancer types where RNU6-919P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.325	0.573	<.001	114	view →
LIHC	DFS	Tertile	All	0.223	0.554	<.001	72	view →
KICH	OS	Tertile	All	0.082	0.877	<.001	63	view →
READ	DFS	Tertile	All	0.255	0.844	.004	63	view →
ACC	DFS	Tertile	All	0.137	0.771	<.001	45	view →
BRCA	DFS	Tertile	II,III,IV	0.751	0.894	.001	36	view →
HNSC	DFS	Tertile	III,IV	0.050	0.611	<.001	36	view →
UCS	DFS	Tertile	III,IV	0.134	0.440	.008	36	view →
THYM	DFS	Tertile	II,III,IV	0.190	0.751	.010	30	view →
PAAD	DFS	Tertile	II,III,IV	0.226	0.464	.001	27	view →
ESCA	DFS	Tertile	II,III,IV	0.672	0.477	.038	21	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-919P–KIRC (OS)

Open the KIRC breakdown →